The National Foundation for Cancer Research is proud to present the Salisbury Award in honor of the Salisbury family’s vision and legacy of funding “high-risk, high-impact and high-reward” cancer research. Over 80 years of service, the three Salisburys galvanized NFCR into a significant force in cancer research worldwide.
The Salisbury Award encourages and promotes innovative scientists and laboratories to translate discoveries into experimental therapies with potential to improve the lives of cancer patients. The initiative is designed to catalyze and advance promising research innovations onto the path of commercialization. Help spread the word!
2021 Salisbury Award Competition
The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.
Read about the updated status of and NFCR’s continued support
to the 2019 Salisbury Award Competition winner.
Salisbury Award-Winning Technology
Entering Next Phase to Reach Clinics